Figure 3. (a) Sections showing cellular tumor comprising of round to fusiform cells, arranged around blood vessels with intervening collagen (20× hematoxylin and eosin). (b) Immunohistochemistry showing positivity for CD34. (c) Immunohistochemistry showing positivity for BCL2. (d) Immunohistochemistry showing positivity for CD99. (e) Negative immunohistochemistry for SMA. (f) Negative immunohistochemistry for cytokeratin.
